Atul Dandekar

CSBO

Atul Dandekar (CSBO) filed 9 Form 4 reports in the trailing twelve months (0 purchases, 9 sales), most often in Maze Therapeutics, Inc. (MAZE). The largest single filing was $2.9M of MAZE (72,400 sh across 2 lots, as filed), executed Dec 29 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 9 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$4.8M

shares × price, as filed

Last traded

Aug 28

Filed Aug 31

Median ADV $16.9M across their filed names

Open performance→

Volume by month

Buys $0 Sells $4.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 9 filings

Sector per market data · by filing · past 12 months

Most traded names

MAZE

Maze Therapeutics, Inc. MAZE · 0 buys · 9 sells 9 filings

Recent filings

MAZESALE Maze Therapeutics, Inc. View filing → $207K
7,500 sh × $27.58
Exec Aug 28
Filed Aug 31 · 6:32 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $194K
7,100 sh × $27.31
Exec Jul 29
Filed Jul 31 · 4:15 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $210K
7,500 sh × $28.02
Exec Jun 29
Filed Jul 1 · 4:17 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $198K
7,500 sh × $26.34
Exec May 29
Filed Jun 2 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $190K
7,500 sh × $25.37
Exec Apr 29
Filed May 1 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $196K
6,710 sh × $29.26
Exec Mar 30
Filed Apr 1 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $341K
7,500 sh across 2 lots
Exec Feb 27
Filed Mar 3 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $280K
6,300 sh across 2 lots
Exec Jan 29
Filed Feb 2 · 5:30 PM ET More filings →